Sarah Henshaw is Data Scientist at the Global MSAT team at Boehringer Ingelheim where she has been working for almost ten years in different positions focusing leading various operations technology and technical transfer projects among local and global manufacturing sites and cross-functional teams. She holds a Master of Business Administration (MBA) from Park University.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.